We are live on ! Find out more
AGRX

Agile Therapeutics
AGRX

Delisted

AGRX was delisted on the 25th of March, 2024.

Back to rankings

41 hedge funds and large institutions have $86.5M invested in Agile Therapeutics in 2017 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 8 increasing their positions, 12 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

18% more capital invested

Capital invested by funds: $73.6M → $86.5M (+$12.9M)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

15% less funds holding

Funds holding: 48 → 41 (-7)

33% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 12

41% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 17

Holders
41
Holders Change
-7
Holders Change %
-14.58%
% of All Funds
1.02%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
10
Increased
8
Reduced
12
Closed
17
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
+$2.7M
2
NIM
Needham Investment Management
New York
+$706K
3
Millennium Management
Millennium Management
New York
+$450K
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$284K
5
Goldman Sachs
Goldman Sachs
New York
+$284K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$1.99M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$927K
3
State Street
State Street
Massachusetts
-$512K
4
Northern Trust
Northern Trust
Illinois
-$415K
5
BCM
Bridgeway Capital Management
Texas
-$263K
Name Holding Trade Value Shares
Change 		Change in
Stake
Janney Montgomery Scott
26
Janney Montgomery Scott
Pennsylvania
$122K +$111K +16 New
COPPSERS
27
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$115K – – –
Barclays
28
Barclays
United Kingdom
$107K +$34.6K +5 +56%
Northern Trust
29
Northern Trust
Illinois
$105K -$415K -60 -81%
ARTA
30
A.R.T. Advisors
New York
$97K +$90K +13 New
Deutsche Bank
31
Deutsche Bank
Germany
$88K -$20.8K -3 -20%
Bank of New York Mellon
32
Bank of New York Mellon
New York
$71K -$125K -18 -64%
PPA
33
Parametric Portfolio Associates
Washington
$55K -$20.8K -3 -30%
VKH
34
Virtu KCG Holdings
New York
$48K – – –
GT
35
Glenmede Trust
Pennsylvania
$29K – – –
TRCT
36
Tower Research Capital (TRC)
New York
$22K +$13.8K +2 +200%
Bank of America
37
Bank of America
North Carolina
$19K -$6.92K -1 -25%
Morgan Stanley
38
Morgan Stanley
New York
$11K -$55.4K -8 -80%
QCG
39
Quadrant Capital Group
Ohio
$9K – – –
UBS Group
40
UBS Group
Switzerland
$8K +$6.92K +1 New
Wells Fargo
41
Wells Fargo
California
$6K -$6.92K -1 -50%
Manulife (Manufacturers Life Insurance)
42
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$3K – – –
BNP Paribas Financial Markets
43
BNP Paribas Financial Markets
France
$1.96K – – –
MAM
44
Meeder Asset Management
Ohio
$1K -$6.92K -1 Closed
Northwestern Mutual Wealth Management
45
Northwestern Mutual Wealth Management
Wisconsin
$1K – – –
State Street
46
State Street
Massachusetts
– -$512K -79 Closed
TCIM
47
TIAA CREF Investment Management
New York
– -$128K -20 Closed
Renaissance Technologies
48
Renaissance Technologies
New York
– -$109K -17 Closed
TA
49
Teachers Advisors
New York
– -$98K -15 Closed
California State Teachers Retirement System (CalSTRS)
50
California State Teachers Retirement System (CalSTRS)
California
– -$87K -14 Closed
1
2
3

AGRX Hedge Fund Activity: Q2 2017 in Review

41 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Agile Therapeutics (AGRX) for Q2 2017, worth a combined $86.5M — up 18% from $73.6M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of AGRX and 10 opened new positions — a net loss of 7 holders — while 12 trimmed existing stakes and 8 added.

The largest buyer was Franklin Resources, adding an estimated $2.7M. The largest seller was BlackRock, cutting an estimated $1.99M.

  • 41 institutional investors held Agile Therapeutics (AGRX) as of Q2 2017, down from 48 in Q1 2017.
  • Funds reported $86.5M of Agile Therapeutics stock for Q2 2017, up 18% quarter-over-quarter.
  • 10 funds opened new Agile Therapeutics positions in Q2 2017 and 17 closed out, a net change of -7 holders.
  • The largest Agile Therapeutics buyer in Q2 2017 was Franklin Resources, an estimated $2.7M added.
  • The largest Agile Therapeutics seller in Q2 2017 was BlackRock, an estimated $1.99M sold.

Based on aggregated 13F filings for Q2 2017.